Led by Dr. Ming Guo, the team identified a new gene involved in the neurological disorder, a finding that could eventually lead to a new target for treatment.
The task force, which included UCLA's Dr. Gary Mathern, created a new definition that broadens the scope of the brain disease and expands the number of people who can be considered to have epilepsy.
Study results shed light on how genetic changes cause autism on a molecular level and will help scientists identify targets for future autism research.
Members of the UCLA delegation are pioneering research related to the new initiative, which will fund projects seeking new ways to treat, cure and prevent brain disorders.
"Today, our scientists are mapping the human brain to unlock the answers to Alzheimer’s; developing drugs to regenerate damaged organs; devising new material to make batteries 10 times more powerful. ... Now is the time to reach a level of research ...